WindRose Health Investors Makes Strategic Investment in Stellus Rx

WindRose健康投资者对Stellus Rx进行战略投资

NEW YORK, December 8, 2025-- WindRose Health Investors, LLC ('WindRose'), a New York-based healthcare private equity firm, today announced that it has made a strategic investment in Stellus Rx ('Stellus Rx' or the 'Company'), a technology-enabled, value-based pharmacy care management platform. The terms of the transaction were not disclosed..

纽约，2025年12月8日——总部位于纽约的医疗保健私募股权公司WindRose Health Investors, LLC（“WindRose”）今日宣布，已对技术驱动的价值导向型药房护理管理平台Stellus Rx（“Stellus Rx”或“公司”）进行了战略性投资。交易条款尚未披露。

Stellus Rx provides personalized, pharmacist-led services that improve clinical outcomes and reduce healthcare costs by simplifying the medication journey for patients and healthcare providers. Providers, payors, employers, and other risk-bearing entities partner with Stellus Rx to optimize the value of medications for patients—through improved medication adherence, timely outreach and interventions, ongoing clinical support, and convenient dispensing services..

Stellus Rx 提供个性化的、由药剂师主导的服务，通过简化患者和医疗服务提供者的用药流程，改善临床结果并降低医疗成本。医疗服务提供者、支付方、雇主及其他承担风险的实体与 Stellus Rx 合作，通过提高用药依从性、及时的沟通与干预、持续的临床支持以及便捷的配药服务，优化患者药物的价值。

WindRose's investment will support Stellus Rx's continued growth, including the expansion of its clinical and operational capabilities and the scaling of its platform to serve additional patient populations across the country.

WindRose的投资将支持Stellus Rx的持续增长，包括扩展其临床和运营能力，以及扩大其平台规模以服务全国更多的患者群体。

'This partnership with WindRose marks a significant milestone for Stellus Rx, as we continue to scale our pharmacist-led platform and ensure that even more people receive the full benefit and value from their prescribed medications,' said Tony Willoughby, Chief Executive Officer of Stellus Rx. 'WindRose's deep healthcare expertise and collaborative approach make them an ideal partner.

“与WindRose的这一合作标志着Stellus Rx的一个重要里程碑，因为我们继续扩展以药剂师为主导的平台，并确保更多人从他们的处方药物中获得充分的利益和价值，”Stellus Rx首席执行官Tony Willoughby表示。“WindRose在医疗保健领域的深厚专业知识和协作方式使他们成为理想的合作伙伴。”

We look forward to our work together, as we continue to help millions of people achieve better health outcomes through a fully supported medication experience.'.

我们期待着共同努力，继续通过全面支持的药物体验帮助数百万人获得更好的健康结果。

'Stellus Rx is a highly differentiated, technology-enabled platform with a proven ability to improve healthcare quality and lower total medical costs,' said Alex Buzik, Partner at WindRose. 'We are excited to partner with Tony and the Stellus Rx team to scale a model that combines clinical excellence with value-based outcomes.'.

“Stellus Rx 是一个高度差异化、技术驱动的平台，拥有提高医疗质量并降低总体医疗成本的经验证能力，”WindRose 合伙人 Alex Buzik 表示。“我们很高兴与 Tony 和 Stellus Rx 团队合作，扩大一个将临床卓越性与基于价值的结果相结合的模式。”

Robert W. Baird & Co. acted as financial advisor to Stellus Rx. Goodwin Procter LLP served as legal advisor to Stellus Rx. McDermott Will & Schulte LLP served as legal advisor to WindRose. TripleTree served as financial advisor to WindRose.

罗伯特·W·贝尔德公司担任Stellus Rx的财务顾问。Goodwin Procter LLP担任Stellus Rx的法律顾问。McDermott Will & Schulte LLP担任WindRose的法律顾问。TripleTree担任WindRose的财务顾问。

About Stellus Rx

关于Stellus Rx

Based in Plano, TX, Stellus Rx provides pharmacist-led patient support and dispensing solutions that sustainably improve patients' health outcomes and reduce total cost of care. The company's technology-enabled teams connect with patients to optimize medications and guide them toward healthier behaviors.

总部位于德克萨斯州普莱诺的Stellus Rx提供由药剂师主导的患者支持和配药解决方案，可持续改善患者的健康结果并降低护理总成本。公司通过技术赋能的团队与患者联系，优化药物治疗并引导他们走向更健康的行为。

Through this work—including a care model that's especially impactful for people with chronic and complex conditions—Stellus Rx serves as a trusted partner for healthcare providers, payors, employers and other risk-bearing entities that seek to change the health and cost trajectory for patients nationwide.

通过这项工作——包括对患有慢性病和复杂病症的人群尤其有影响力的护理模式——Stellus Rx 成为了医疗保健提供者、支付方、雇主以及其他承担风险的实体值得信赖的合作伙伴，这些实体致力于改变全国患者的健康和成本轨迹。

Learn more at stellusrx.com..

请访问stellusrx.com了解更多信息。

About WindRose Health Investors

关于风向标健康投资者

New York City-based WindRose makes equity investments in companies that operate within the services sectors of the healthcare industry. The firm focuses on companies with profitable business models and a demonstrated ability to deliver cost-effective solutions. With approximately $7 billion under management, WindRose invests in companies throughout the United States.

总部位于纽约市的 WindRose 对医疗保健行业服务领域内的公司进行股权投资。该机构专注于拥有盈利商业模式并具备提供高性价比解决方案能力的公司。WindRose 管理着约 70 亿美元资产，投资于美国各地的公司。

For more information, please email us at info@windrose.com..

更多信息，请发送电子邮件至 info@windrose.com。

Contact:

联系人：

Caroline Luz

卡罗琳·卢兹

Lambert by LLYC

兰伯特 by LLYC

203-570-6462

203-570-6462

cluz@lambert.com

cluz@lambert.com